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1013-118 Impaired Coronary Microcirculation Evidenced by 
Abnormal Thrombolysis in Myocardial Infarction Frame 
Counts in Patients With Transient Left Ventricular 
Apical Ballooning Syndrome
Kevin A. Bybee, Abhiram Prasad, Gregory W. Barsness, Amir Lerman, Joseph G. 
Murphy, Allan S. Jaffe, R. Scott Wright, Charanjit S. Rihal, Mayo Clinic and Foundation, 
Rochester, MN
Background: The mechanisms responsible for transient left ventricular apical ballooning
syndrome (TLVABS) are unknown. We evaluated TIMI frame counts in patients with TLV-
ABS to assess coronary microcirculatory function.
Methods: We identified 11 patients meeting the following criteria:1) new ST segment/T
wave changes on the presenting electrocardiogram; 2) a coronary angiogram revealing
no stenosis greater than 70%; 3) LV apical ballooning with akinesis or dyskinesis extend-
ing beyond a single major coronary artery distribution. TIMI frame counts were calculated
in the LAD, RCA, and circumflex coronary arteries of the TLVABS patients and compared
with 11 gender-matched control patients who underwent coronary angiography prior to
valve surgery and were free of obstructive CAD. A Students t-test was used to assess for
statistical significance between groups.
Results: All 11 patients were white females and underwent coronary angiography within
24 hours of hospital admission. TIMI frame counts were significantly higher in the LV api-
cal ballooning patients compared with controls: LAD(corrected): 43 versus 24; circumflex:
47 versus 27; RCA: 37 versus 24; p< 0.05 for all comparisons.
Conclusion: Transient left ventricular apical ballooning syndrome is characterized by
abnormally large TIMI frame counts in all 3 major epicardial coronary arteries suggesting
that diffuse microvascular dysfunction with enhanced microcirculatory resistance may
play a role in the pathogenesis of the syndrome. 
1013-119 B-Type Natriuretic Peptide Levels in Asymptomatic 
Patients With B-Thalassaemia Major
Georgios P. Pavlakis, Konstantina Bouki, Komninos Komninos, Dimitra Vini, Marouso 
Drosou, Dimitris Georgiou, Evangelos Papasteriadis, Eleni Konstantellou, General 
Hospital of Nikea, Piraeus, Greece
Background: The leading cause of mortality in patients with b-thassaemia major is car-
diomyopathy due to myocardial iron overload or myocarditis. The purpose of this study
was the early detection of cardiomyopathy in patients with b-thalassaemia major based
on plasma B-Natriuretic Peptide (BNP) levels and the correlation of BNP values with the
echocardiographic and Magnetic Resonance Imaging (MRI) measurements.
Methods : The study cohort consisted of 130 patients (pts) (mean age 31± 9 years) with
b-thalassaemia major who have been transfused periodically and 50 age-matched
healthy volunteers. All the pts were asymptomatic and none of them had a past history of
heart failure. In all pts with b-thalassaemia major, plasma NT-proBNP and serum ferritin
levels were measured, and an echocardiographic study was performed. In 40 pts mea-
surement of T2 star relaxation time was done by using ECG-gating, heart MRI. Plasma
NT-proBNP levels were also measured in the control group.
Results : Elevated NT-proBNP levels were found in 118/130 pts (90%) compared with
the values of the control group (mean values 658 ± 358 fmol/lt Versus 180 ± 100 fmol/lt
respectively, P<0.0001). A statistically significant correlation was found between left ven-
tricular (LV) end-diastolic diameter and NT-proBNP levels (r=0.51, P=0.0068), LV end-
systolic diameter and NT-proBNP levels (r=0.58, P=0,0012) and also among NT-proBNP
levels and the grade of tricuspid regurgitation (TR) (r=0.77, P<0.0001). No significant cor-
relation was found between NT-proBNP and ferritin levels, while there was a trend of
inverse correlation between NT-proBNP levels and T2 star MRI measurements (r=-0.27,
P=0.2).
Conclusion : Plasma NT-proBNP levels increase in the majority of asymptomatic pts
with b-thalassaemia major. NT-proBNP values correlate positively with LV dimensions
and the grade of TR, as estimated by echocardiography. However, the new MRI method
of T2 star relaxation time, as well as serum ferritin levels do not seem to correlate with
NT-proBNP levels in these pts. Although our results are preliminary, it seems that estima-
tion of BNP levels is useful for the early detection of cardiomyopathy in asymptomatic
patients with b-thalassaemia major.
1013-120 Validation of Criteria for Noncompacted Myocardium in 
Dilated Cardiomyopathy, Valvular, and Hypertensive 
Heart Disease
Barbara S. Frischknecht, Christine H. Attenhofer Jost, Erwin N. Oechslin, Burkart Seifert, 
Philipp Hoigné, Malgorzata Roos, Rolf Jenni, University Hospital Zurich, Zurich, 
Switzerland
Background. Echocardiographic criteria typical of isolated left ventricular noncompac-
tion (IVNC) rarely occur in valvular or hypertensive heart disease (HHD) or dilated cardi-
omyopathy (IDC). The aim of this study was to analyze frequency of IVNC criteria
including hypertrabeculation (>3 trabecles) in these diseases. Methods. Retrospectively,
echocardiographic and clinical findings of 19 patients with IVNC were compared to 31
with IDC, 22 with HHD, and 86 with severe chronic valvular heart disease: (22 patients
with mitral regurgitation (MR) due to prolapse; 20 with aortic regurgitation (AR), 44 with
aortic stenosis (AS), 20 controls. Neuromuscular disease was an exclusion criterion. The
last echocardiographic exam of each patient was reviewed blindly to analyze specificity of
IVNC criteria. Results. Clinical characteristics and ECG findings did not differentiate
between IVNC and other diseases. The ejection fraction was higher in IVNC compared to
IDC (p<0.0001). The frequency of typical noncompaction criteria is shown in the Table. It
may occur in other disease, however without wall thickening of these segments which is
rare in patients without IVNC. Hypertrabeculation is not helpful (sensitivity in IVNC 11 %).
Conclusion. Although some criteria used in noncompaction are occasionally found in
other heart disease, the combination of all criteria is very specific. In patients without
neuromuscular disease, hypertrabeculation may not be a sensitive criterion.
POSTER SESSION
1031 Heart Failure: Genetic Polymorphisms
Sunday, March 07, 2004, Noon-2:00 p.m.
Morial Convention Center, Hall G
Presentation Hour: 1:00 p.m.-2:00 p.m.
1031-103 Genetic Heterogeneity of the Nitric Oxide Synthase 3 
Locus and Heart Failure Outcomes: Comparison of the 
T786C Promoter, Intron 4b/a and the Asp298Glu 
Polymorphisms
Maninder S. Bedi, Srinivas Murali, Guy Macgowan, Linda Cadaret, Michael Mathier, 
Barry London, Dennis McNamara, University of Pittsburgh, Pittsburgh, PA
Three common polymorphisms exist for NOS3 gene: Asp298Glu, Intron 4b/a 27 bp repeat
and the T786C promoter. We have previously shown that the Asp298Glu polymorphism
affects heart failure outcomes.However, these three polymorphisms are linked, and their
relative clinical impact remains controversial. We sought to evaluate the impact of the
promoter and intronic NOS3 polymorphism on event free survival and whether the vari-
ants exhibited linkage disequilibrium.
Methods: NOS 3 genotyping was performed on 469 patients (72% male, 49% ischemic,
age 56 ± 12 years, LVEF 0.24±0.08) enrolled in a prospective study of Genetic Risk
Assessment of Cardiac events (GRACE) and followed to an endpoint of death or cardiac
transplantation. For genotype analysis, patients were grouped by the presence or
absence of the Asp298, C786 or the intron 4a variant. Event-free survival was then com-
pared within genetic subsets. Baseline blod pressure, heart rate, NYHA class, etiology,
VO2max and LVEF was also compared between the groups. Linkage disequilibrium was
assessed by Chi-square analysis.
Results: Linkage disequilibrium was evident between Asp298Glu and both the promoter
(p<0.001) and the intronic polymorphisms (p<0.001). Comparisons of LVEF, baseline
heart rate and blood pressure demonstrated no significant difference by genotype class
for all the three genotype variants. Event-free survival was significantly poorer overall in
subjects with Asp298 (1 year: 79%/83%: 2 year: 67%/72%, p=0.03). In contrast, there
was no difference in survival in patients with and without the C786 variant (1 year: 81%/
81%, 2 year: 72%/69%, p=0.33) and for patients with and without the intron 4a variant (1
year: 80%/81%, 2 year 71%/69%, p= 0.26). Asp298 was associated with worseVO2 max
(p=0.016) and higher NYHA Class (p=0.07) than the other variants.
Conclusion: The three common polymorphic loci of NOS 3 are in significant linkage dis-
equilibrium. However, while the Asp298 variant modulates clinical outcomes in heart fail-
ure, little impact was evident for the promoter and intronic polymorphisms of NOS3. This
suggests the clinical impact of the Asp298 variant is not due to linkage disequilibrium with
the other two loci.
Controls IVNC IDC HHD AR MR AS p value
2-layered structure 0 % 100 % 26 % 5 % 10 % 9 % 7 % <0.0001
Perfused recesses 0 % 95 % 48 % 9 % 10 % 9 % 5 % <0.0001
Hypokinetic 
segments
0 % 89 % 97 % 59 % 40 % 5 % 32 
%
<0.0001
Meshwork 0 % 68 % 3 % 5 % 10 % 9 % 7 % <0.0001
Hypertrabeculation 0 % 11 % 0 % 0 % 0 % 0 % 2 % 0.14
Noncompacted 
segments including 
walthickening
0 % 100 % 3 % 5 % 0 % 0 % 5 % <0.0001
